{
  "ticker": "IMRX",
  "company_name": "Immuneering Corporation",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06208124",
      "title": "A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Advanced Solid Tumor (Phase 1), Pancreas Adenocarcinoma, Non-small Cell Lung Cancer, Malignant Melanoma (Cutaneous)",
      "start_date": "2024-02-27",
      "completion_date": "2025-04-30",
      "enrollment": 0,
      "sponsor": "Immuneering Corporation"
    },
    {
      "nct_id": "NCT05585320",
      "title": "A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Advanced Solid Tumor, Pancreatic Adenocarcinoma, Malignant Melanoma (Cutaneous), Non-small Cell Lung Cancer (NSCLC)",
      "start_date": "2022-10-31",
      "completion_date": "2027-06",
      "enrollment": 0,
      "sponsor": "Immuneering Corporation"
    }
  ],
  "summary": {
    "total_trials": 2,
    "by_phase": {
      "PHASE1, PHASE2": 2
    },
    "by_status": {
      "COMPLETED": 1,
      "ACTIVE_NOT_RECRUITING": 1
    },
    "active_trials": 1,
    "completed_trials": 1,
    "conditions": [
      "Advanced Solid Tumor (Phase 1), Pancreas Adenocarcinoma, Non-small Cell Lung Cancer, Malignant Melanoma (Cutaneous)",
      "Advanced Solid Tumor, Pancreatic Adenocarcinoma, Malignant Melanoma (Cutaneous), Non-small Cell Lung Cancer (NSCLC)"
    ],
    "lead_stage": "unknown"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:19:01.508661",
    "search_query": "Immuneering Corporation",
    "url": "https://clinicaltrials.gov/search?term=Immuneering+Corporation"
  }
}